OBJECTIVES: The aim of this study was to compare perioperative outcomes in young adults following isolated Ross procedure versus mechanical aortic valve replacement (AVR) in a high-volume centre.
INTRODUCTION
Aortic valve replacement (AVR) represents one of the most common cardiac operations in adults under 65 years of age. However, the ideal aortic valve substitute in this patient population remains unknown. A higher life expectancy exposes these patients to an increased risk of valve-related complications. Mechanical prostheses (MPs) represent a durable option with a low risk of reintervention and are often considered the option of choice in young adults with aortic disease. However, MPs expose patients to the risk of thromboembolic events and anticoagulation-related complications. In a recent study of 450 consecutive adults under 65 years of age undergoing isolated elective mechanical AVR at our centre, long-term survival was below the age-and gender-matched general population [1] . The Ross procedure offers several advantages in young adults. It provides excellent haemodynamics, avoids the burden of long-term anticoagulation and results in improved patient quality of life [2, 3] . In addition, recently published studies on long-term outcomes in patients undergoing the Ross procedure reported survival equivalent to the age-and gender-matched general population [4] [5] [6] [7] . However, the Ross procedure is a longer and more complex procedure, which requires intervention on two valves rather than one [8] .
In recent years, significant improvements in cardiopulmonary bypass (CPB) circuits, imaging techniques and intensive care unit (ICU) management have led to overall improvements in outcomes, following more complex procedures. Whether the increased complexity of the Ross procedure is associated with increased early morbidity and mortality remains a matter of debate. A recent study, examining early outcomes following the Ross procedure in the STS database, shows a 2.7% operative mortality, which was significantly higher than matched conventional AVRs [9] . At the Montreal Heart Institute (MHI), we started a dedicated Ross program in 2011 for all patients under 60 years of age with aortic valve disease. The aim of this propensity-matched cohort study was to compare early outcomes in adults following a Ross procedure versus mechanical AVR in the current era at a high-volume centre.
MATERIALS AND METHODS

Patient population
From 2007 to 2015, 990 consecutive adults ≤65 years of age underwent either a mechanical AVR or a Ross procedure at the MHI. Of these, 138 patients underwent a Ross procedure between 2011 and 2015, whereas 852 underwent mechanical AVR between 2007 and 2015. From 2011 onwards, all patients ≤60 years of age were systematically considered for a Ross procedure, including patients with previous cardiac procedure, patients with endocarditis or requiring concomitant procedures. Patients were not considered for a Ross procedure if they had an anticipated life expectancy of <15 years (chronic renal dialysis, diffuse coronary artery disease with left ventricular dysfunction, chronic autoimmune disorders). To compare two homogeneous groups, we aimed to analyse outcomes only after isolated AVR. Thus, only elective and first-do operations were considered. Exclusion criteria were: concomitant procedures other than ascending aortic replacement, redo operations or urgent surgery. In total, 557 patients were excluded [515 (60%) patients in the mechanical AVR cohort and 42 (30%) patients in the Ross cohort]. The remaining 433 patients were eligible for inclusion (Fig. 1 ). Of these, 337 (78%) had an isolated mechanical AVR and 96 (22%) a Ross procedure, with concomitant ascending aortic replacement in 58 patients in the AVR group (17%) and 78 patients in the Ross group (57%). To mitigate the effects of measurable baseline confounders, patients were matched into 70 pairs using propensity score matching. The population flowchart is presented in Fig. 2 , and baseline patient characteristics are summarized in Table 1 . The study was approved by the MHI institutional review board, and a waiver of consent was obtained.
Surgical procedures
All procedures were performed through a standard median sternotomy. All Ross procedures were performed by three surgeons (I. El-Hamamsy, N. Poirier and R. Cartier). The technique used for the Ross procedure was a total root replacement in all cases. Details of the surgical technique have been previously described [8] . Briefly, during autograft harvesting, the infundibular muscle was trimmed to leave no more than 2-3 mm below the cusp insertion line. The autograft root was then placed in an intrannular position, using single interrupted sutures. In patients with aortic insufficiency and dilated aortic annulus, an extra-aortic annuloplasty was performed (n = 13). The pulmonary valve was replaced by a cryopreserved pulmonary homograft (Cryolife Inc., Kennesaw, GA), using interrupted sutures. Intermittent antegrade and continuous retrograde blood cardioplegia was used in all cases. For AVR with mechanical prosthesis, the valve was implanted, using interrupted pledgetted mattress sutures. Both supra-and intra-annular techniques were used in our centre according to the surgeon's preference. Antegrade and retrograde blood cardioplegia were also used in all cases.
Outcomes and data collection
All data were prospectively collected through the MHI valve clinic and our Ross registry. Additional data were gathered from medical records. All patient echocardiograms were individually reviewed. Follow-up was 100% complete.
Outcomes were reported according to the STS guidelines for reporting mortality and morbidity after cardiac valve interventions [10] . The primary outcome was early mortality (<30 days postoperatively). Secondary outcomes were perioperative myocardial infarction (elevated cardiac enzymes with ST-elevation changes), prolonged intubation (>24 h), neurological complications (stroke, transient ischaemic attack and delirium), acute kidney injury (AKI) (>2-fold postoperative creatinine increases and >2 mg/dl), reintervention for bleeding, transfusion, arrhythmia (atrial fibrillation and complete AV block) and the mean aortic gradient at discharge. In addition, major postoperative complications were combined in a composite secondary end-point which included: death, dialysis, stroke, reintervention for bleeding and prolonged intubation.
Statistical analysis
A logistic regression, predicting the choice of operation (Ross versus mechanical AVR), was conducted for all baseline characteristics presented in Table 1 . Nine variables significantly different between mechanical AVR and Ross patients in the unmatched population were identified. Therefore, a propensity score was performed to match the Ross group patients with the mechanical AVR group (1:1) according to age, ascending aorta aneurysm, aortic root aneurysm, NYHA functional class, hypertension, pulmonary hypertension, surgical indication for AVR, left ventricle ejection fraction <50% and dyslipidaemia. Patients were matched using the nearest neighbour method without replacement and a calliper width equal to 0.1. The mean distance in the estimated propensity scores was 1.6 ± 3.3%. Propensity scores' kernel distributions before and after matching are shown in Fig. 3 .
In the overall population, a logistic regression was used to estimate the risk of major postoperative complications according to the patient's group. Variables screened as potential confounders were the preoperative baseline characteristics. All variables with a P-value of <0.10 upon univariate analysis were considered as having a potential confounding effect. Additionally, variables deemed to be of clinical significance were considered as potential confounders and were forced in the multivariable model. A nonautomated variable selection was performed.
Continuous data were expressed as median [interquartile range] and categorical variables were presented as frequency (%). Continuous variable were compared using Mann-Whitney U-test, and categorical variables were compared with χ 2 or Fisher exact test as appropriate. Patient characteristics in the matched cohort were also compared using standardized differences. A difference of >0.20 was considered significant. Outcomes of the matched cohort were compared, using generalized estimating equation linear or logistic regressions with the matching unit as the random effect. Table 1 shows the baseline characteristics of the unmatched and matched cohorts. The propensity score matching resulted in a total cohort of 140 patients, undergoing isolated mechanical AVR or Ross procedure with or without concomitant ascending aortic replacement (n = 70 in each group). Median age and EuroSCORE II were similar in the two groups. Aortic stenosis was the indication in 97 patients (69%), aortic regurgitation in 19 patients (13%) and mixed aortic disease in 24 patients (17%). About 25% of patients had an ascending aortic aneurysm in mechanical AVR group. Three patients (4%) had left ejection fraction <50% in each group.
RESULTS
Matched cohort characteristics
Operative data
Operative details of the matched cohort are summarized in Table 2 . The ascending aorta was replaced in 32 (46%) patients in the Ross group and 19 (27%) patients in the mechanical AVR group (P = 0.03). Hypothermic circulatory arrest was required in 4 (6%) patients undergoing the Ross procedure and 1 (1%) patient undergoing mechanical AVR (P = 0.21). Median CBP times were respectively, 212 [42] and 91 [42] min in the Ross and mechanical AVR groups (P < 0.001), whereas median cross-clamp times were, respectively, 187 [29] and 67 [34] (P < 0.001).
Perioperative outcomes
Perioperative outcomes for the unmatched and matched populations are presented in Table 3 . In the matched cohort, there were no early mortalities in either group. There were no perioperative myocardial infarctions in either group. Ten (14%) patients experienced postoperative AKI in the Ross cohort, whereas 2 cases were documented in the mechanical AVR group (P < 0.03). Of these patients, 2 (2%) required temporary dialysis with complete recovery of renal function (P = 0.25). No patient had a permanent pacemaker implantation in the Ross group, whereas 5 (7%) patients undergoing mechanical AVR required a permanent pacemaker implantation (P = 0.02). Three (4%) patients had a reintervention for bleeding in the Ross group versus 6 (9%) in the mechanical AVR group (P > 0.49). Twentyseven (39%) patients received at least one transfusion in the Ross group, whereas 22 (31%) did so in the mechanical AVR group (P = 0.47).
The median ICU length of stay was 2 [2] days in the Ross group and 1 [1] day in the mechanical AVR group (P < 0.001), whereas the median hospital length of stay was 6 [2] days in both the groups.
At discharge, mean aortic valve gradient was 5.8 [3.2] In multivariable analysis (Table 4) , the Ross procedure was not a predictor of major complications in the unmatched cohort [OR 1.3 CI (0.6-2.8); P = 0.55].
DISCUSSION
Findings from this propensity-matched cohort study suggest that the operative mortality risk in adults undergoing elective isolated mechanical AVR or the Ross procedure in a dedicated highvolume centre, is similar. One of the concerns with the Ross procedure is that the increased surgical complexity of the procedure compared with that of standard AVR would translate into poorer perioperative outcomes. Indeed, in a recent study by Reece et al. examining outcomes following the Ross procedure in the STS database between 1994 and 2010, the authors report an operative mortality 3-fold higher than conventional AVR after matching the patients using a propensity score (2.7 vs 0.9%, respectively) [9] . This, according to the authors, supports the fact that the Ross procedure does not represent a viable alternative to conventional AVR in the majority of adults [9] . Although, on the basis of their findings, this is a reasonable statement, it should also be weighed against the fact that 198 of the 220 centres reporting Ross procedures had performed less than 5 cases over the total period of the study (16 years) [9] . As with any complex procedure (valvesparing operations, minimally invasive procedures, thoracoabdominal procedures etc.), outcomes are often correlated with surgical volumes [11] [12] [13] . The small volumes reported by Reece et al. were further corroborated in a recent report from the STS database, examining overall volumes of aortic root operations from 2004 to 2010. The authors showed that the median number of annual aortic root procedures per centre in the STS database was 2, and 95% of the centres perform <16 aortic root operations per year [14] . It is therefore apparent that one of the main issues with the Ross procedure in the STS database was directly related with centrespecific surgical volumes. In 2011, on the basis of emerging longterm data in the literature demonstrating good long-term outcomes following the Ross procedure in young adults [4, 6, 15] , we started a dedicated Ross programme at our institution (Fig. 1) . We, therefore, aimed to evaluate outcomes of these patients versus standard mechanical AVR. In contrast to registry data, results suggest that in terms of operative mortality, the Ross procedure can be considered a safe alternative to standard AVR in adults undergoing primary elective AVR, despite the fact that these are significantly longer and more complex operations. Importantly, this was not a single surgeon's experience. All Ross procedures in this study were performed by three surgeons, using the same surgical technique [8] , supporting the notion that the operation is reproducible in a highvolume centre. In addition, this cohort includes our learning curve with this operation.
In this study, patients, undergoing redo or concomitant procedures (other than ascending aortic replacement), were excluded from the original match to avoid introducing too much heterogeneity within and between both cohorts. The principal objective was to evaluate the safety of the Ross procedure as an alternative to conventional AVR in first-time, elective settings. Although operative risk is certainly higher in patients undergoing more complex procedures (redos, emergent operations, concomitant procedures), this should be weighed against the potential benefit of the operation on an individual patient basis (level of physical activity, desire for pregnancy). Although this comparison should be performed to define the role of the Ross procedure in this setting, this study did not specifically address that point.
The most frequent perioperative complication observed in the Ross cohort was the occurrence of acute renal failure, which in some cases required temporary dialysis (n = 2). Although all patients recovered normal kidney function, there are reports suggesting that postoperative renal failure has a direct impact on short-and long-term outcomes after cardiac surgery [16] [17] [18] . In our cohort, no direct impact on operative mortality was observed. However, longer term follow-up is required to assess its role on late outcomes in this specific population of patients with little associated burden of atherosclerosis. Thus far, our long-term follow-up is too short to adequately evaluate that question. Part of the explanation for the higher rates of acute renal failure in the Ross cohort is directly related to the length of CPB required in these patients. This results in haemolysis in a number of patients, which could be a contributing factor. After the initial 30 patients, some important modifications to the management of the patients were introduced. Notably, we stopped using intraoperative acute normovolemic haemodilution (2 units were harvested per patient in the initial experience). In addition, in the initial experience, strict blood pressure control was instituted immediately after cross-clamp removal (maximum systolic BP 90-100 mmHg). In contrast, systolic BP is now allowed to reach 120 mmHg in the first few hours to ensure adequate kidney perfusion. Once urine output is satisfactory and no residual signs of haemolysis are visible, blood pressure targets are lowered to protect the pulmonary autograft. Finally, non-steroidal anti-inflammatories (NSAIDs) were started on postoperative day 1, which may have contributed to acute renal failure. This has also been modified, and no NSAIDs are given prior to postoperative day 2 at minimum, or until serum creatinine normalizes. Together, we believe that these changes could improve renal outcomes following the Ross procedure in our cohort. In contrast to renal outcomes, there were no differences observed in terms of myocardial or neurological injury or hospital lengths of stay. ICU length of stay was 1 day longer in the Ross cohort because of the emphasis on tight BP control in these patients, thus requiring the presence of an arterial cannula for invasive BP monitoring. Interestingly, although the Ross procedure is a significantly longer operation, the rates of re-exploration for bleeding were similar between the groups, as well as the need for any blood production transfusion (39% in the Ross cohort). This highlights the safety of this operation as an alternative to conventional AVR in young adults.
Limitations
This study has several limitations. First, despite the propensitymatching process, there probably remain inherent hidden differences between the two groups, which only a prospective randomized trial could overcome. Preoperative clinical judgement and 'eye-ball' evaluation of the patient cannot be included in a retrospective study. Although the study period was rather limited, the Ross procedure was performed only in the latter part of the time period following institution of our program in 2011, thus including our learning curve. Although the periods are not completely overlapping, few changes in operative technique, surgical technology or patient management have occurred within that period to affect 
CONCLUSION
In conclusion, current findings suggest that, in a high-volume centre with expertise in the Ross procedure, no differences in operative risk are observed between a Ross procedure and a mechanical AVR in young adults undergoing elective isolated AVR.
Further analyses are required to compare outcomes in higher risk patient groups. Nevertheless, these data support the notion that the Ross procedure can be offered as a safe alternative to conventional AVR in high-volume centres. Longer-term follow-up is nevertheless required to evaluate the benefit of this approach in terms of clinically relevant outcomes.
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